Post by
FarmerBetty on Apr 24, 2023 6:49pm
Vaccine data
For those wondering about the vaccine results show a robust antibody response against the ABO epitope was observed wtih both adjuvants and was remarkably maintained unabated out to 6 months after the last immunization. The serum antibodies reacted with ABO only, not monomers or plaque.
Conclusion a vaccine consisting of an ABO- restricted conformational B cell conjugated to KHL produced a strong Abeta antibody response with no measurable pro-inflammatory T cell response against Abeta. In addition, the oligomer selectivity of the antibodies focused the response on pathogenic ABO, portentially reducing the risk of ARIA-E associated with binding to plaque and vascular deposits of Abeta.
Comment by
goldtech on Apr 24, 2023 9:24pm
Farmer Betty do I take this post as an acknowledgement that we are on the right track? I know where your coming from and yes it's been years of corporate mismanagement, but let's give Gail some time and see. Great post by the way.